Trading / Browse Companies / Epic Sciences Stock

Epic Sciences Stock

epicsciences.comHealthcareFounded: 2008Funding to Date: $161MM

Epic Sciences is a developer of novel diagnostics designed to personalize and advance the treatment and management of cancer.

Buy or sell Epic Sciences stockLearn more about a potential Epic Sciences IPO
Register for Details

For more details on financing and valuation for Epic Sciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Epic Sciences.

Register Today

Team

Management Team

Pascal Bamford Ph.D
Chief Scientific Officer and Head of Laboratory Operations
Dena Marrinucci Ph.D
Co-Founder & Member Clinical Advisory Board
Murali Prahalad Ph.D
Chief Executive Officer & President
Ryan Dittamore
Chief of Medical Innovation and Head of Translational Research Partnerships
Ian Miller JD
Chief Business Officer and General Counsel
Dave Henderson
Chief Information Officer

Board Members

Evgeny Zaytsev Ph.D
RusnanoMedInvest
Kim Kamdar Ph.D
Domain Associates
John Sage
Andrew ElBardissi MD
Deerfield Management
Peter Kuhn Ph.D
Gregory Critchfield MD
Gregory Lucier
Simon Greenwood Ph.D
Roche Venture Fund

Other companies like Epic Sciences in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.6B
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Nutrafol
Sector
Healthcare
Last Round Est. Valuation
$150MM
Biosplice Therapeutics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Levels
Sector
Healthcare
Last Round Est. Valuation
$296.3MM
Cerebral
Sector
Healthcare
Last Round Est. Valuation
$4.8B

News

FinSMEs 09/12/2018
Epic Sciences Closes $52M in Series E Financing | FinSMEs
Epic Sciences, a San Diego, CA-based developer of blood tests that predict therapeutic benefit for cancer patients, completed a $52m Series E financing

Trending Companies

Frequently Asked Questions